The objective of this study is to evaluate the clinical performance of ColoClear test in early screening of colorectal cancer in Hong Kong. Other outcomes to analyze include, but are not limited to the point estimate of the sensitivity of ColoClear for the detection of advanced adenoma (AA) in Hong Kong.
Age
40–74
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subject is at average risk for development of CRC.
Subject is male or female (all Asian), 40-74 years of age.
Subject is able to comprehend, sign and date the written informed consent form to participate in this study, undergo study procedures described in the informed consent form and authorizes release of relevant protected health information through signing an informed consent form.
You may not be if
Subject undergone colonoscopy and removal of lesions within 5 years.
Subject with Familial Adenomatous Polyposis (FAP) and Inflammatory Bowel Disease (IBD) including chronic ulcerative colitis (CUC) and Crohn's disease.
Subject with overt rectal bleeding, e.g., hematochezia or melena, within the previous 30 days.
Any condition which, in the opinion of the investigator should preclude participation in the study.
